Core C - Genomics, Animal Models and Advanced Phenotyping Core

核心 C - 基因组学、动物模型和高级表型分析核心

基本信息

  • 批准号:
    10403631
  • 负责人:
  • 金额:
    $ 38.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-05 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

CORE C – GENOMICS, ANIMAL MODELS AND ADVANCED PHENOTYPING PROJECT SUMMARY/ABSTRACT The goal of the Cardiorenal and Metabolic Disease Research Center (CMDRC) COBRE is to bring together a multidisciplinary group of basic, clinical, and population scientists to work synergistically on the theme of cardiorenal and metabolic diseases. During Phase 1, CMDRC-Core C provided COBRE investigators and external researchers' access to technical expertise and equipment to perform a wide variety of molecular, genetic, microarray and gene expression studies that would otherwise not be possible. Core C also provided investigators at UMMC access to novel transgenic and knockout mouse and rat models of cardiovascular renal and metabolic disease that are only available at UMMC. In total, CMDRC-Core C completed several hundred genomic studies as well as generated thousands of animals for detailed phenotyping resulting in numerous publications and several NIH R01 funded grants. In Phase II, CMDRC-Core C major project, pilot grants, and external researchers will have access to state-of-the-art genomic technologies through the Genomics Sub-Core and large collection of animal models (inbred, transgenic, and gene-edited rat and mouse models) as well as advanced phenotyping methodologies through the Animal Models and Advanced Phenotyping Sub-Core. Core C has four aims: (1) to provide CMDRC investigators access to technical expertise and cutting-edge genomic services, including next generation sequencing technologies (RNA sequencing, 16S microbial sequencing, custom amplicon panels, whole genome sequencing, and exome sequencing); (2) to provide CMDRC investigators access to large collection of unique animal models of obesity, cardiorenal and metabolic diseases, along with training in advanced phenotyping techniques; (3) to provide education and training opportunities for students, trainees, and faculty in genomics technologies and advanced animal phenotyping; and (4) to provide continuous improvement in existing assays, services, and enhance technological capabilities through acquisition of new cutting-edge instrumentation that will assist in sustainability of the Core. Therefore, it is the objective of the CMDRC-Core C to aid investigators in advancing scientific discovery in obesity, cardiorenal, and metabolic diseases through application of state-of-the-art genomic technologies, specialized animal models, and advanced physiological measurements to generate greater insight into these diseases. Aside from CMDRC investigators, continued funding of the COBRE during Phase II will have a significant impact on providing external researchers (at other Mississippi undergraduate institutions and Historically Black Colleges and Universities (HBCUs)] access to equipment and expertise that would otherwise not be available in our region of the country.
核心C -基因组学、动物模型和高级表型分析 项目总结/摘要 肾脏和代谢疾病研究中心(CMDRC)COBRE的目标是汇集 一个由基础、临床和人口科学家组成的多学科小组,协同工作, 心肾和代谢疾病。在第1阶段,CMDRC核心C提供了COBRE研究者, 外部研究人员可以获得技术专长和设备, 基因,微阵列和基因表达研究,否则将是不可能的。核心C还提供了 UMMC的研究人员获得了新的转基因和基因敲除小鼠和大鼠心血管模型 肾脏和代谢疾病,只有在UMMC可用。总的来说,CMDRC核心C完成了几个 数百项基因组研究以及产生数千只动物进行详细的表型分析, 许多出版物和几个NIH R 01资助的赠款。在第二阶段,CMDRC-核心C重大项目,试点 赠款,外部研究人员将有机会获得最先进的基因组技术,通过 基因组学子核心和大量动物模型(近交系、转基因和基因编辑的大鼠和 小鼠模型)以及通过动物模型和高级 表型亚核心。核心C有四个目标:(1)为CMDRC调查人员提供技术 专业知识和尖端的基因组服务,包括下一代测序技术(RNA 测序、16 S微生物测序、定制扩增子面板、全基因组测序和外显子组 测序);(2)为CMDRC研究人员提供大量独特的动物模型, 肥胖、心肾和代谢疾病,沿着高级表型技术的培训;(3) 为学生、学员和教职员工提供基因组学技术方面的教育和培训机会, 先进的动物表型分析;以及(4)在现有的检测、服务和 通过采购新的尖端仪器来提高技术能力, 核心的可持续性。因此,CMDRC核心C的目的是帮助研究者推进 通过应用最先进的技术,在肥胖、心肾和代谢疾病方面的科学发现 基因组技术、专门的动物模型和先进的生理测量, 对这些疾病有更深入的了解。除了CMDRC的调查人员外,COBRE在2009年期间继续获得资金, 第二阶段将对提供外部研究人员产生重大影响(在其他密西西比本科生中 机构和历史上的黑人学院和大学(HBCU)]获得设备和专业知识, 否则在我国的这一地区将无法获得。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL R GARRETT其他文献

MICHAEL R GARRETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL R GARRETT', 18)}}的其他基金

Omics, Bioinformatics and Flow Cytometry Core
组学、生物信息学和流式细胞术核心
  • 批准号:
    10630580
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
Project 1 - TBD
项目 1 - 待定
  • 批准号:
    10553868
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
Molecular Center of Health and Disease
健康与疾病分子中心
  • 批准号:
    10553864
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
Core B-Omics and Gene-Editing
核心 B 组学和基因编辑
  • 批准号:
    10553866
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
Core A- Administration, Education, and Mentoring
核心 A- 管理、教育和指导
  • 批准号:
    10553865
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
Genetic Targets of Hypertension End Organ Damage
高血压终末器官损伤的遗传靶标
  • 批准号:
    10198017
  • 财政年份:
    2018
  • 资助金额:
    $ 38.62万
  • 项目类别:
Genetic Targets of Hypertension End Organ Damage
高血压终末器官损伤的遗传靶标
  • 批准号:
    9920359
  • 财政年份:
    2018
  • 资助金额:
    $ 38.62万
  • 项目类别:
Core C - Genomics, Animal Models and Advanced Phenotyping Core
核心 C - 基因组学、动物模型和高级表型分析核心
  • 批准号:
    10159921
  • 财政年份:
    2013
  • 资助金额:
    $ 38.62万
  • 项目类别:
Genetics of Renal End Organ Damage in Hypertension
高血压肾终末器官损伤的遗传学
  • 批准号:
    8477235
  • 财政年份:
    2009
  • 资助金额:
    $ 38.62万
  • 项目类别:
Genetics of Renal End Organ Damage in Hypertension
高血压肾终末器官损伤的遗传学
  • 批准号:
    8289584
  • 财政年份:
    2009
  • 资助金额:
    $ 38.62万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 38.62万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
  • 批准号:
    23KK0126
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.62万
  • 项目类别:
    Training Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了